A Florida court recently issued a ruling in the case of Myra Rozar v. R.J. Reynolds Tobacco Company, which could have significant implications for how evidence is presented in tobacco-related lawsuits. Rozar, who has chronic obstructive pulmonary disease (COPD), challenged a previous court's decision regarding the admissibility of certain medical evidence and the adequacy of the damages awarded to her. This ruling affects not only Rozar but also other plaintiffs in similar cases against tobacco companies.
Rozar initially filed her lawsuit against R.J. Reynolds in 2008, as part of a larger group of cases stemming from the landmark Engle v. Liggett Group, Inc. ruling in 2006. This ruling allowed smokers to seek damages from tobacco companies for health issues related to smoking. Rozar, who began smoking in the 1950s, was diagnosed with COPD in 1994. Her case reached the District Court of Appeal of Florida after she appealed a trial court's decisions regarding evidence and damages.
The dispute centers on whether the trial court wrongly allowed evidence of Rozar's unrelated health issues, including a previous lawsuit against a breast implant manufacturer, to influence the jury's decision. Rozar argued that this evidence was irrelevant and prejudicial, which could have affected the jury's view of her case. Additionally, she sought a new trial on the grounds that the jury's damage award was inadequate, particularly regarding pain and suffering.
In its ruling, the court affirmed in part and reversed in part the trial court's decisions. The court ruled that the trial court did not abuse its discretion by allowing the jury to consider Rozar's broader health history, stating, "Given Rozar’s history of medical problems overlapping with her COPD, we cannot conclude that the trial court abused its discretion by allowing the jury to broadly consider the extent to which her multi-million-dollar damages claims were partly attributable to other, non-COPD medical problems." The judges involved in the decision were Osterhaus, Lewis, and B.L. Thomas.
However, the court also found that the jury's decision to award Rozar nothing for past pain and suffering was inadequate. The court noted that the evidence presented at trial supported Rozar's claims of significant pain and suffering due to her COPD. The judges stated, "Under § 768.74(5)’s criteria and the uncontroverted evidence, the zero verdict for past pain and suffering is inadequate." The court reversed the trial court's denial of Rozar's motion for a new trial on this specific issue.
This ruling has important implications for future cases involving tobacco companies and similar health-related lawsuits. It highlights the court's willingness to scrutinize jury decisions regarding damages, particularly in cases where the evidence of suffering is clear. The decision may encourage other plaintiffs in tobacco-related cases to challenge jury awards that they believe do not adequately reflect their suffering.
Moving forward, Rozar's case will return to the trial court for further proceedings regarding the past pain and suffering damages. The court's ruling also raises questions about the admissibility of medical evidence in similar lawsuits, potentially influencing how future cases are handled. It remains to be seen whether R.J. Reynolds will seek to appeal this decision or if there are related cases pending that could be affected by this ruling.